Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber/Boston Children’s assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a for a discussion about your care.
Can we help you find something?
Our specialized new patient coordinators can answer your questions about treatment options and becoming a patient.
President, Dana-Farber/Boston Children's Cancer and Blood Disorders Center Chairman, Pediatric Oncology, Dana-Farber Cancer Institute Associate Chief, Division of Hematology/Oncology, Boston Children’s Hospital David G. Nathan Professor of Pediatrics, Harvard Medical School
Dr. Scott A. Armstrong earned his medical degree and PhD from University of Texas Southwestern Medical School in 1996. After internship and residency training with the Boston Combined Residency Program (BCRP), he completed a hematology/oncology fellowship at Dana-Farber/Boston Children’s. Subsequently, he completed his research training here with Dr. Stanley Korsmeyer. He is a Professor of Pediatrics at Harvard Medical School. The major focus of his career has been delineating the biology of childhood cancers and the development of new therapeutic approaches for children with cancer.
David Williams, MD
Senior Vice President and Chief Scientific Officer, Boston Children's Hospital Chief, Division of Hematology/Oncology, Boston Children’s Hospital Associate Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute Institute Physician Leland Fikes Professor of Pediatrics, Harvard Medical School
Dr. David A. Williams is a graduate of Indiana State University and Indiana University School of Medicine. After training in Pediatrics at Cincinnati Children's Hospital Medical Center, Dr. Williams completed fellowship training in Pediatric Hematology/Oncology at Dana-Farber/Boston Children's. He completed his research training here and at the Whitehead Institute at the Massachusetts Institute of Technology. He then became a faculty member at Harvard Medical School and of the Howard Hughes Medical Institute (HHMI).
Lisa Diller, MD
Vice Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute Chief Medical Officer, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Director, David B. Perini Jr Quality of Life Clinic for Childhood Cancer Survivors, Dana-Farber Cancer Institute Institute Physician, Dana-Farber Cancer Institute Attending Physician, Division of Hematology/Oncology, Department of Pediatrics, Boston Children’s Hospital Professor of Pediatrics, Harvard Medical School
Dr. Lisa Diller is the Vice Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and the Chief Medical Officer, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. She is also the Director of the Perini Family Survivors Center and the David B. Perini Jr. Quality of Life Clinic at Dana-Farber Cancer Institute. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelor's degree from Harvard University and earned her medical degree from the University of California at San Diego.
John Whiting, DNP, RN, CCRN
Associate Chief Nurse, Clinical and Patient Care Operations, Boston Children's Hospital
Jon Whiting is Vice President and Associate Chief Nurse of Clinical and Patient Care Operations at Boston Children’s Hospital. Jon serves as the Leadership Co-Chair of the Boston Children’s Hospital Family Advisory Council. In partnership with the Chief Experience Officer at Boston Children’s Hospital, Jon leads the Office of Experience. Jon provides system-level leadership to advance nursing and hospital-wide initiatives ranging from safe and effective care delivery for a broad scope of patients and care services to providing organization-wide leadership during emergencies, including COVID-19. Jon is passionate about improving aspects of patient and family care experiences, and he is committed to partnering with patients and families to do so.
Barbara Cuccovia, PhD, RN, BMTCN
Director of Nursing, Pediatric Oncology, Dana-Farber Cancer Institute
Barbara Cuccovia is Director of Nursing, Pediatric Oncology, at Dana-Farber Cancer Institute where she oversees the daily and clinical operations of the Jimmy Fund Clinic. She is leading an initiative to transform the nursing model in the pediatric clinic, and she serves as clinical advisor to Dana-Farber’s Pediatric Patient and Family Advisory Council. Previously, she was Nurse Manager of the Stem Cell Transplant Unit at Boston Children’s Hospital. Barbara serves on the Association of Pediatric Hematology Oncology Nursing (APHON) and is president of the local Boston APHON Chapter. She earned her bachelor’s degree in nursing from the State University of New York at Binghamton and her master’s degree in nursing, nursing leadership, and health systems management from Drexel University.